2 results
Approved WMOCompleted
The main objective of Study M15-722 is to characterize the efficacy, safety, and tolerability of ravagalimab (ABBV-323) as induction treatment in subjects with moderately to severely active UC.
Approved WMOPending
The objectives of this clinical investigation are:1. To demonstrate that the FIRE1* Sensor can be safely deployed into the inferior vena cava (IVC) 2. To demonstrate that the FIRE1* Sensor can provide a signal to the FIRE1* External System3. To…